-
公开(公告)号:US12187714B2
公开(公告)日:2025-01-07
申请号:US18328267
申请日:2023-06-02
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC: C07D413/14
Abstract: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additionally, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US20220281861A1
公开(公告)日:2022-09-08
申请号:US17704718
申请日:2022-03-25
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC: C07D413/14
Abstract: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US11286253B2
公开(公告)日:2022-03-29
申请号:US17115037
申请日:2020-12-08
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC: C07D413/14
Abstract: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US11198684B2
公开(公告)日:2021-12-14
申请号:US16633756
申请日:2018-07-25
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Doo-Byung Lee , Jung-Ae Lee , Jun-Sup Lee , Hyun Ju , Woo-Seob Shin , Sang-Seol Jeon
IPC: C07D265/30 , C07D295/135 , C07D403/04 , C07D413/14
Abstract: The present invention provides intermediates useful for the synthesis of an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors; and processes for preparing the same. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US10889578B2
公开(公告)日:2021-01-12
申请号:US16633684
申请日:2018-07-25
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC: C07D413/14
Abstract: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US12227478B2
公开(公告)日:2025-02-18
申请号:US17594062
申请日:2020-04-03
Applicant: YUHAN CORPORATION
Inventor: Sang-Ho Oh , Doo-Byung Lee , Kyoung-Chan Kwon , Sang-Won Kim , Hyo-Ick Hwang , Kyeong-Sill Lee , Ik-Su Jo , Ji-Hye Choi , Sung-Hee Cho , Su-Young Lee
IPC: C07D211/56 , C07D487/04
Abstract: Provided are a process for preparing (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine or a salt thereof, which is an intermediate useful for the preparation of tofacitinib, an intermediate used in the process, i.e., isopropanol solvate of methyl ((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)carbamate dibenzoyl-L-tartrate, an intermediate, having excellent stability, useful for the preparation of tofacitinib, i.e., (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine acetate, and a process for preparing tofacitinib or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US11708362B2
公开(公告)日:2023-07-25
申请号:US17704718
申请日:2022-03-25
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC: C07D413/14
CPC classification number: C07D413/14
Abstract: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US20230312545A1
公开(公告)日:2023-10-05
申请号:US18328267
申请日:2023-06-02
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC: C07D413/14
CPC classification number: C07D413/14
Abstract: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additionally, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US20210269427A1
公开(公告)日:2021-09-02
申请号:US17115037
申请日:2020-12-08
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Seong-Ran Lee , Hyun Ju , Woo-Seob Shin , Dae-Gyu Park , Su-Min Park , Yoon-Ah Hwang
IPC: C07D413/14
Abstract: The present invention provides an improved process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. Additional, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
公开(公告)号:US10858353B2
公开(公告)日:2020-12-08
申请号:US16633695
申请日:2018-07-25
Applicant: Yuhan Corporation
Inventor: Sang-Ho Oh , Ja-Heouk Khoo , Jong-Chul Lim , Doo-Byung Lee , Jung-Ae Lee , Jun-Sup Lee , Hyun Ju , Woo-Seob Shin , Sang-Seol Jeon
IPC: C07D413/14 , C07D265/32 , C07D403/10
Abstract: The present invention provides a novel process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.
-
-
-
-
-
-
-
-
-